NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain

por Pierre Arsenault, Dan Chiche, William Brown, Jeffrey Miller, Roi Treister, Richard Leff, Philippe Walker, Nathaniel Katz
Publicado 2018-12-01